CZL goes deep and comes back with big grades

|

Published 08-APR-2016 11:39 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Consolidated Zinc (ASX:CZL) has gone deep at Plomosas, and come back with zinc grades reaching nearly 48%.

The ASX-listed junior explorer told its shareholders yesterday that it had received assays back from 10 previously drilled holes, making it 42 holes which have been drilled at the project.

The latest set focused on both the deeper ‘Level 7’, and the shallower Tres Amigos zone.

The higher grade results, however, came from the deeper drilling which is testing an extension to the main mineralisation zone.

Results included:

Sample hits from 10 holes as part of CZL's drilling campaign

Sample hits from 10 holes as part of CZL’s drilling campaign

The continued high grade hits at both Tres Amigos and the deeper Level 7 will be a fillip to CZL as it continues to work towards a maiden JORC resource.

“Drilling continues to return excellent grades at both Tres Amigos and from the deeper zone within the mine and drilling is planned to continue with multiple rigs in order to continue to expand the footprint of mineralisation,” CZL managing director Will Dix said.

“The company continues to work towards our maiden JORC resources at both Tres Amigos and from the semi oxide and sulphide zones beneath level 7”

About CZL and Plomosas

The main project for CZL is the Plomosas Zinc Project in Mexico.

It has been mined to the tune of 2 million tonnes of ore in the past, with an average zinc + lead grade of 22%. It has mined down to 270m below the surface.

CZL currently has a 51% stake in the project, but is aiming to increase this to above 80%.

It covers 11 exploration concessions covering over 3000 hectares in the northern Mexican state of Chihuahua, about two hours flight from Dallas to the north east.

CZL is aiming to initially focus on a 200tpd processing plant which is already present on site, using cashflow from early production to fund exploration.

Graphic showing drilling at the Plomosas project

Graphic showing drilling at the Plomosas project



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X